Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1

被引:70
作者
Richard, DJ
Schumacher, V
Royer-Pokora, B
Roberts, SGE [1 ]
机构
[1] Univ Dundee, Wellcome Trsut Bioctr, Dept Biochem, Div Gene Express, Dundee DD1 5EH, Scotland
[2] Univ Dusseldorf, Inst Human Genet & Anthropol, D-40001 Dusseldorf, Germany
关键词
WT1; par4; transcription; coactivator;
D O I
10.1101/gad.185901
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The Wilms' tumor suppressor protein WT1 is a transcriptional regulator involved in differentiation and the regulation of cell growth. WT1 is subject to alternative splicing, one isoform including a 17-amino acid region that is specific to mammals. The function of this 17-amino acid insertion is not clear, however. Here, we describe a transcriptional activation domain in WT1 that is specific to the WT1 splice isoform that contains the 17-amino acid insertion. We show that the function of this domain in transcriptional activation is dependent on a specific interaction with the prostate apoptosis response factor par4. A mutation in WT1 found in Wilms' tumor disturbs the interaction with par4 and disrupts the function of the activation domain. Analysis of WT1 derivatives in cells treated to induce par4 expression showed a strong correlation between the transcription function of the WT1 17-amino acid insertion and the ability of WT1 to regulate cell survival and proliferation. Our results provide a molecular mechanism by which alternative splicing of WT1 can regulate cell growth in development and disease.
引用
收藏
页码:328 / 339
页数:12
相关论文
共 55 条
[1]   Mutation analysis of the WT1 gene in sporadic childhood leukaemia [J].
Algar, E ;
Blackburn, D ;
Kromykh, T ;
Taylor, G ;
Smith, P .
LEUKEMIA, 1997, 11 (01) :110-113
[2]   INTERACTION OF HUMAN THYROID-HORMONE RECEPTOR-BETA WITH TRANSCRIPTION FACTOR TFIIB MAY MEDIATE TARGET GENE DEREPRESSION AND ACTIVATION BY THYROID-HORMONE [J].
BANIAHMAD, A ;
HA, I ;
REINBERG, D ;
TSAI, S ;
TSAI, MJ ;
OMALLEY, BW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8832-8836
[3]   Donor splice-site mutations in WT1 are responsible for Frasier syndrome [J].
Barbaux, S ;
Niaudet, P ;
Gubler, MC ;
Grunfeld, JP ;
Jaubert, F ;
Kuttenn, F ;
Fekete, CN ;
SouleyreauTherville, N ;
Thibaud, E ;
Fellous, M ;
McElreavey, K .
NATURE GENETICS, 1997, 17 (04) :467-470
[4]   RNA binding by the Wilms tumor suppressor zinc finger proteins [J].
Caricasole, A ;
Duarte, A ;
Larsson, SH ;
Hastie, ND ;
Little, M ;
Holmes, G ;
Todorov, I ;
Ward, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7562-7566
[5]  
Cook DM, 1996, ONCOGENE, V13, P1789
[6]  
Davies R, 1999, CANCER RES, V59, p1747S
[7]   WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes [J].
Davies, RC ;
Calvio, C ;
Bratt, E ;
Larsson, SH ;
Lamond, AI ;
Hastie, ND .
GENES & DEVELOPMENT, 1998, 12 (20) :3217-3225
[8]   REPRESSION OF THE TRANSFORMING GROWTH-FACTOR-BETA-1 GENE BY THE WILMS-TUMOR SUPPRESSOR WT1 GENE-PRODUCT [J].
DEY, BR ;
SUKHATME, VP ;
ROBERTS, AB ;
SPORN, MB ;
RAUSCHER, FJ ;
KIM, SJ .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (05) :595-602
[9]   Constitutional WT1 mutations in Wilms' tumor patients [J].
Diller, L ;
Ghahremani, M ;
Morgan, J ;
Grundy, P ;
Reeves, C ;
Breslow, N ;
Green, D ;
Neuberg, D ;
Pelletier, J ;
Li, FP .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3634-3640
[10]   REPRESSION OF THE INSULIN-LIKE GROWTH FACTOR-II GENE BY THE WILMS-TUMOR SUPPRESSOR WT1 [J].
DRUMMOND, IA ;
MADDEN, SL ;
ROHWERNUTTER, P ;
BELL, GI ;
SUKHATME, VP ;
RAUSCHER, FJ .
SCIENCE, 1992, 257 (5070) :674-678